Evidence map›Paper›PMID 29400579›Full record

ArticleEndocrine research2018

Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Yu-Kwang Donovan Tay, Minghao Liu, Leonardo Bandeira, Mariana Bucovsky, James A Lee, Shonni J Silverberg, Marcella D Walker

Open access · greenAbstract read
In one paragraph

Article in Endocrine research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Subclinical urolithiasis in patients with asymptomatic primary hyperparathyroidism.Therapeutic advances in endocrinology and metabolism · 2018
    Article
  14. Primary Hyperparathyroidism.The Journal of clinical endocrinology and metabolism · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yu-Kwang Donovan Taya Division of Endocrinology, Department of Medicine , Columbia University, College of Physicians and Surgeons , New York.
Minghao Liua Division of Endocrinology, Department of Medicine , Columbia University, College of Physicians and Surgeons , New York.
Leonardo Bandeiraa Division of Endocrinology, Department of Medicine , Columbia University, College of Physicians and Surgeons , New York.
Mariana Bucovskya Division of Endocrinology, Department of Medicine , Columbia University, College of Physicians and Surgeons , New York.
James A Leed Department of Endocrine Surgery , Columbia University , New York , USA.
Shonni J Silverberga Division of Endocrinology, Department of Medicine , Columbia University, College of Physicians and Surgeons , New York.
Marcella D Walkera Division of Endocrinology, Department of Medicine , Columbia University, College of Physicians and Surgeons , New York.
Columbia University · USSengkang General Hospital · SG

Funding

Non-Classical Manifestations of Primary HyperparathyroidismK24DK074457 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SILVERBERG, SHONNI J · 2006 to 2016
$1.7M
Primary Hyperparathyroidism: Neurocognitive FeaturesR21DK104105 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WALKER, MARCELLA DONOVAN · 2015 to 2016
$440k
NIDDK NIH HHS K24 DK074457NIDDK NIH HHS R21 DK104105
6 · The paper itself

Abstract

objectiveRecent international guidelines suggest renal imaging to detect occult urolithiasis in all patients with asymptomatic primary hyperparathyroidism (PHPT), but data regarding their prevalence and associated risk factors are limited. We evaluated the prevalence and risk factors for occult urolithiasis.

methodsCross-sectional analysis of 96 asymptomatic PHPT patients from a university hospital in the United States with and without occult nephrolithiasis.

resultsOccult urolithiasis was identified in 21% of patients. Stone formers had 47% higher 24-hour urinary calcium excretion (p = 0.002). Although available in only a subset of patients (n = 28), activated vitamin D [1,25(OH)

conclusionOccult urolithiasis is present in about one-fifth of patients with asymptomatic PHPT and is associated with higher urinary calcium and 1,25(OH)

Indexed as

25-Hydroxyvitamin D 2AgedCalciumCross-Sectional StudiesFemaleHumansHyperparathyroidism, PrimaryMaleMiddle AgedSensitivity and SpecificityUrolithiasis25-Hydroxyvitamin D 2CalciumAsymptomaticimagingoccult nephrolithiasispredictorsprimary hyperparathyroidismstones

Identifiers

PMID29400579
PMCPMC6042842
OpenAlexW2790603899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.